Skip to main content

Optinose seeking $40M from stock sale to advance drug-device combo product

The company is working on getting a second approval for its flagship product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.